Ipamorelin (10mg)
Specyfikacja techniczna
| Czystość (HPLC) | ≥99% (HPLC) |
| Numer CAS | 170851-70-4 |
| Forma | White lyophilized powder |
| Przechowywanie | -20°C |
| Sekwencja | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Masa cząsteczkowa | 711.85 g/mol |
| Forma soli | Acetate |
| Rozpuszczalność | Soluble in water |
Ipamorelin (10mg)
Cena katalogowa w EUR · HU, SK, CZ, PL
- Eurozone (EUR)160,00 EUR
- Węgry (HU)160,00 EUR≈ 64 000 Ft
- Słowacja (SK)160,00 EUR
- Czechy (CZ)160,00 EUR≈ 4 000 Kč
- Polska (PL)160,00 EUR≈ 680,00 zł
Ta sama cena katalogowa w EUR przy dostawie na Węgry, Słowację, Czechy i Polskę. Płatność w EUR.
Orientacyjne kwoty HUF, CZK i PLN przeliczone z EUR; Słowacja stosuje EUR. Kursy przybliżone. Płatność w EUR.
Ipamorelin 10 mg — większy format selektywnego agonisty receptora greliny; do rozbudowanych protokołów badawczych osi GH. Wyłącznie RUO — do badań laboratoryjnych; nie do spożycia przez ludzi.
Wyłącznie do badań laboratoryjnych.
Nie do spożycia przez ludzi, zastosowań weterynaryjnych ani diagnostycznych.
From the Peptide Explorer
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Key Mechanisms
- ›GHSR-1a (ghrelin receptor) agonism
- ›Selective GH pulse amplification
- ›Minimal cortisol/prolactin elevation
- ›No appetite stimulation (unlike GHRP-6)
- ›Synergy with GHRH analogs
Primary Research Areas
- ›GH secretion
- ›Body composition
- ›Bone density
- ›Age-related GH decline
- ›Selective secretagogue research
Key Research Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Overview
A selective growth hormone secretagogue that stimulates GH release via the ghrelin/GHSR-1a receptor without significantly affecting cortisol, ACTH, or prolactin levels. This selectivity distinguishes it from other GHRPs like GHRP-6 and hexarelin.
Origin: Synthetic pentapeptide GH secretagogue developed by Novo Nordisk
Mechanism of Action
- GHSR-1a (ghrelin receptor) agonism
- Selective GH pulse amplification
- Minimal cortisol/prolactin elevation
- No appetite stimulation (unlike GHRP-6)
- Synergy with GHRH analogs
Primary Research Areas
- GH secretion
- Body composition
- Bone density
- Age-related GH decline
- Selective secretagogue research
Key Published Findings
- Stimulated GH release comparable to GHRP-6 without cortisol or prolactin elevation
- Demonstrated dose-dependent GH release with a wider therapeutic window
- Synergistic GH amplification when combined with CJC-1295
Research Protocol
Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted
Important Notice
Ipamorelin (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specyfikacja badawcza
Synthesized for strict analytical consistency. Verified via HPLC/MS.Zobacz standardy jakości →
Przechowywanie i obsługa
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water